LinkedIn




FDA

FDA Press Release: Changes to the Edurant (rilpivirine) label: drug-drug interaction update
Posted: May 2014
FDA Press Release: FDA Approves First Human Papillomavirus Test for Primary Cervical Cancer Screening
Posted: April 2014
FDA Press Release: HIV/AIDS Update - Tentative approval: lamivudine and tenofovir disoproxil fumarate FDC tablets with nevirapine
Posted: March 2014
New Guidance for Industry Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment
Posted: June 2013
FDA Reopening Comment Period for Notice of Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research
Posted: August 2013
FDA Updates Efavirenz Labeling with Expanded Pediatric Indication Information
Posted: May 2013
FDA Approves Dolutegravir, a New Drug to Treat HIV-1 Infection
Posted: August 2013
FDA Approves First Rapid Diagnostic Test for Simultaneous Detection of HIV-1 Antigen and Both HIV-1 and HIV-2 Antibodies
Posted: August 2013
FDA approves Prezista (darunavir) labeling changes
Posted: April 2013
FDA Updates Atripla Labeling
Posted: April 2013
FDA Approved Changes to the Intelence (Etravirine) Label
Posted: March 2013
FDA Recently Approved Changes to the Prezista (Darunavir) Label
Posted: March 2013
FDA Updates Complera Labeling with New Indication and Clinical Trial Information
Posted: February 2013
FDA Updates Darunavir Tablet and Oral Suspension Labeling with Pediatric Dosing Information
FDA Updates Atazanavir Sulfate Capsule Labeling
Posted: February 2013
Voluntary Recall Announced for One Lot of Cidofovir Injection (Vistide) Solution
Posted: February 2013
FDA Approves First Anti-Diarrheal Drug for People with HIV/AIDS
Posted: January 2013
FDA Updates Lopinavir/Ritonavir (Kaletra) Labeling to Include New Drug Interaction Information
Posted: January 2013
FDA approved changes to the Edurant (rilpivirine) package insert
Posted: December 2012
FDA approved a labeling change for Hepsera (adefovir dipivoxil) package insert
Posted: December 2012
FDA approved changes to the Viramune XR (nevirapine) Extended-Release Tablet label
Posted: November 2012
FDA approved an 800 mg tablet strength for Prezista (darunavir)
Posted: November 2012
FDA Approves Stribild to Treat HIV Infection
Posted: September 2012
FDA Safety Announcement: Updated Information on Drug Interactions Between Victrelis, an HCV Protease Inhibitor, and Certain HIV Protease Inhibitors
Posted: May 2012
FDA Approves Truvada for PrEP
Updated: July 2012
FDA Approves OraQuick In- Home HIV Test
Posted: July 2012
Truvada for PrEP: FDA Extends Review by 3 Months
Posted: June 2012
FDA Approves Generic Formulations of Lamivudine and Zidovudine Tablets and Nevirapine Tablets and Oral Suspension
Posted: May 2012
Lexiva (Fosamprenavir) Dosing for Pediatric Patients Approved
Posted: April 2012
Intelence (Etravirine): Pediatric Dosing Recommendations and New Scored 25 mg Tablet for Pediatric Dosing
Posted: March 2012
FDA Issues Safety Announcement About Interactions Between Certain HIV or Hepatitis C Drugs and Cholesterol-Lowering Statin Drugs
Posted: March 2012
FDA Notice: Drug Interactions Between Victrelis, An HCV Protease Inhibitor, and Certain HIV Protease Inhibitors
Posted: February 2012
FDA Approves Generic Formulation of Abacavir Tablets
Posted: June 2012
Prezista (darunavir) label update
Posted: June 2012
FDA Updates Tenofovir Disoproxil Fumarate (Viread) Label with New Dosing and Formulation Information
Posted: January 2012
FDA Approves Oral Suspension Formulation of Darunavir (Prezista) and Updates Product Label
Posted: December 2011
FDA Updates Ritonavir (Norvir) Label with New Safety Information
Posted: December 2011
FDA Expands Use of Raltegravir (Isentress) to Treat HIV Infection in Children and Adolescents
Posted: Janaury 2012
FDA Updates Raltegravir (Isentress) Label with New Information on Severe Skin and Hypersensitivity Reactions
Posted: November 2011
FDA Launches Web Site with Information on Safe Disposal of Needles and Other Medical Sharps
Posted: November 2011
FDA Approves Emtricitabine/Rilpivirine/Tenofovir DF (Complera) for the Treatment of HIV in Treatment-Naive Adults
Posted: August 2011
FDA Approves Two New Drugs for Treatment of Chronic Hepatitis C
Posted: May 2011
FDA Approves Rilpivirine (Edurant) for Treatment of HIV in Treatment-Naïve Patients
Posted: May 2011